EUVIMEDEUVIMED entdecken
Multizentrische StudieKohortenstudie

One-Year Outcomes of the First 1000 Patients Implanted With the Medtronic Micra AV Leadless Pacing System in France: The AV-CESAR Cohort Study

Fawzi Kerkouri iD, Nicolas Clementy, Pascal Defaye iD, Mina Ait Said iD, Antoine Andorin iD, Frédéric Anselme iD, Warda Aoudjeghout, Marc Badoz, Nathalie Behar, Nazih Benhenda iD, Mouna Ben Kilani iD, Alexandre Bodin iD und 35 weitere

Circulation: Arrhythmia and Electrophysiology · 2026-06 · 19 (6)

DOI: 10.1161/circep.126.014850 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Circulation: Arrhythmia and Electrophysiology, 2026-06. Verfasst von Fawzi Kerkouri und 46 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, European Georges Pompidou Hospital, France (F.K., W.A., C.J., V.W., E.M.). Hauptthemen laut MEDLINE: Pacemaker, Artificial, Cardiac Pacing, Artificial, Atrioventricular Block, Heart Rate. Die Arbeit nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Evidence supporting the Micra AV leadless pacing system has largely derived from highly experienced centers, potentially limiting generalizability to routine clinical practice. METHODS: The AV-CESAR study (French Cohort Evaluating the Effectiveness of Atrioventricular Synchrony by the micRa AV) is a nationwide retrospective cohort, including the first 1000 patients implanted with a Medtronic Micra AV leadless pacemaker in France (2020–2024). Mean follow-up was 13.4±10.6 months. Primary end points were early (in-hospital) and late (postdischarge) device-related major complications; pacemaker syndrome and need for implantation of a new pacing system were centrally adjudicated. RESULTS: Among 1003 patients, device implantation was successful in 1000 (99.7%). Mean age was 72.0±15 years; 62.8% were men, 44.0% had ≥2 comorbidities, and 62.4% were unsuitable for transvenous pacemakers. The primary indication was permanent complete atrioventricular block with preserved sinus rhythm (78.0%). Early major complications occurred in 2.4%, including pericardial effusion (0.8%; 3 requiring surgery), access-site complications (0.8%), and thromboembolism (0.3%). Late major complications included pacemaker syndrome (2.5%), pacing-induced cardiomyopathy (1.2%), high thresholds (>4 V/0.24ms, 0.3%), and premature battery depletion (0.2%). No device infections or dislodgements were observed. Overall, 2.5% of patients required implantation of a new pacing system (pacing-induced cardiomyopathy n=11; pacemaker syndrome n=7; high threshold n=3; battery/software failure n=3; tricuspid regurgitation n=1) and 12.7% were permanently reprogrammed to ventricular paced/sensed, inhibited (VVI) mode. In pacing-dependent patients with ambulatory Holter monitoring (>3.4 million paced cycles), mean atrioventricular synchrony was 67.6±17.3% and correlated with device-reported AM-VP (74.8±17.1%; R 2 =0.92; P 90 beats per minute (5.6% of monitored time). All-cause mortality was 13.8%, with 0.2% directly device-related; 41.7% of deaths were cardiovascular. CONCLUSIONS: The Micra AV system is primarily used as an alternative when dual-chamber conventional pacemakers are not feasible. It demonstrated acceptable safety and clinical performance in a high-risk population. The marked reduction in atrioventricular synchrony at higher heart rates may suggest limited clinical benefit in patients with higher exertional heart rates. REGISTRATION: URL: https://clinicaltrials.gov/study/NCT05953558 ; Unique identifier: NCT05953558.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pacemaker, ArtificialCardiac Pacing, ArtificialAtrioventricular BlockHeart RateHumansMaleFemaleFranceAgedRetrospective StudiesTreatment OutcomeTime FactorsAged, 80 and overRisk FactorsMiddle AgedEquipment DesignFollow-Up Studies

Stichwörter der Autor:innen

atrioventricular blockcardiac pacing, artificialpacemaker, artificialpostoperative complicationsregistriesreoperationtreatment outcome

Autor:innen und Institutionen

  • Division of Cardiology, European Georges Pompidou Hospital, France (F.K., W.A., C.J., V.W., E.M.).
  • Université Paris Cité, Paris Cardiovascular Research Center, France (F.K., W.A., K.N., V.W., E.M.).
  • Department of Cardiology, University Hospital of Brest, France (F.K., V.M., J.M.).
  • University of Western Brittany, ORPHY Laboratory, Brest, France (F.K., J.M.).
  • Department of Cardiology, Clinique du Millénaire, Montpellier, France (N.C.).
  • Department of Cardiology, University Hospital of Grenoble, France (P.D., P.J.).

ORCID-Profile: Fawzi Kerkouri, Pascal Defaye, Mina Ait Said, Antoine Andorin, Frédéric Anselme, Nazih Benhenda, Mouna Ben Kilani, Alexandre Bodin, Pierre Bordachar, Abdeslam Bouzeman, Olivier Citerne, Jean-Claude Deharo, Carine Dommerc, Mathieu Echivard, Fabrice Extramiana, Laurent Fauchier, Rodrigue Garcia, Edouard Gitenay, Charles Guenancia, Benoît Guy-Moyat, Peggy Jacon, Maciej Kubala, Christophe Leclercq, Christelle Marquié, Alexis Mechulan, Pierre Mondoly, Kumar Narayanan, Pierre Ollitrault, Jean-Luc Pasquié, Angelique Peret, Hervé Poty, Olivier Villejoubert, Victor Waldmann, Serge Boveda, Jacques Mansourati, Eloi Marijon

Zitieren

APA

Kerkouri, F., Clementy, N., Defaye, P., Ait Said, M., Andorin, A., Anselme, F., Aoudjeghout, W., Badoz, M., Behar, N., Benhenda, N., Ben Kilani, M., Bodin, A., Bordachar, P., Bouzeman, A., Citerne, O., Deharo, J. C., Dommerc, C., Echivard, M., Extramiana, F., …, & AV-CESAR Investigators (2026). One-Year Outcomes of the First 1000 Patients Implanted With the Medtronic Micra AV Leadless Pacing System in France: The AV-CESAR Cohort Study. Circulation: Arrhythmia and Electrophysiology, 19(6). https://doi.org/10.1161/circep.126.014850

Vancouver

Kerkouri F, Clementy N, Defaye P, Ait Said M, Andorin A, Anselme F, et al. One-Year Outcomes of the First 1000 Patients Implanted With the Medtronic Micra AV Leadless Pacing System in France: The AV-CESAR Cohort Study. Circulation: Arrhythmia and Electrophysiology. 2026;19(6). doi:10.1161/circep.126.014850

BibTeX
@article{Kerkouri2026,
  author = {Kerkouri, Fawzi and Clementy, Nicolas and Defaye, Pascal and Ait Said, Mina and Andorin, Antoine and Anselme, Frédéric and Aoudjeghout, Warda and Badoz, Marc and Behar, Nathalie and Benhenda, Nazih and Ben Kilani, Mouna and Bodin, Alexandre and Bordachar, Pierre and Bouzeman, Abdeslam and Citerne, Olivier and Deharo, Jean-Claude and Dommerc, Carine and Echivard, Mathieu and Extramiana, Fabrice and Fauchier, Laurent and Garcia, Rodrigue and Gitenay, Edouard and Guenancia, Charles and Guy-Moyat, Benoît and Jacon, Peggy and Jesel, Laurence and Juin, Christophe and Khoueiry, Ziad and Kubala, Maciej and Leclercq, Christophe and Mansourati, Vincent and Marquié, Christelle and Mechulan, Alexis and Mondoly, Pierre and Narayanan, Kumar and Ollitrault, Pierre and Pasquié, Jean-Luc and Peret, Angelique and Poty, Hervé and Sebag, Frederic and Villejoubert, Olivier and Waintraub, Xavier and Waldmann, Victor and Boveda, Serge and Mansourati, Jacques and Marijon, Eloi and AV-CESAR Investigators, AV-CESAR Investigators},
  title = {One-Year Outcomes of the First 1000 Patients Implanted With the Medtronic Micra AV Leadless Pacing System in France: The AV-CESAR Cohort Study},
  journal = {Circulation: Arrhythmia and Electrophysiology},
  year = {2026},
  volume = {19},
  number = {6},
  doi = {10.1161/circep.126.014850}
}
Kostenlos starten →